Efficacy and safety of semaglutide versus placebo in adults with overweight or obesity without diabetes: updated meta-analysis of randomized trials

Rida Wajid, Ravi Kumar, Misbah Muneer, Maria Nauroz Ali, Jazia Ul Mustafa, Javeria Qamar, Daniyal Asif, Saadia Ziaulhaque, Iqra Sohail, Fawaz Ahmed Khamisani, Maria Noureen, Sadaf Fatima, Ali Saqlain, Laksh Kumar, Adarsh Raja

Open source

DOI: 10.1007/s40200-026-02108-x
Published: 2026-10-31
Container: Journal of Diabetes & Metabolic Disorders
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40200-026-02108-x,
  title = {Efficacy and safety of semaglutide versus placebo in adults with overweight or obesity without diabetes: updated meta-analysis of randomized trials},
  author = {Rida Wajid and Ravi Kumar and Misbah Muneer and Maria Nauroz Ali and Jazia Ul Mustafa and Javeria Qamar and Daniyal Asif and Saadia Ziaulhaque and Iqra Sohail and Fawaz Ahmed Khamisani and Maria Noureen and Sadaf Fatima and Ali Saqlain and Laksh Kumar and Adarsh Raja},
  year = {2026},
  journal = {Journal of Diabetes \&amp; Metabolic Disorders},
  doi = {10.1007/s40200-026-02108-x},
  url = {https://doi.org/10.1007/s40200-026-02108-x}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of semaglutide versus placebo in adults with overweight or obesity without diabetes: updated meta-analysis of randomized trials
AU  - Rida Wajid
AU  - Ravi Kumar
AU  - Misbah Muneer
AU  - Maria Nauroz Ali
AU  - Jazia Ul Mustafa
AU  - Javeria Qamar
AU  - Daniyal Asif
AU  - Saadia Ziaulhaque
AU  - Iqra Sohail
AU  - Fawaz Ahmed Khamisani
AU  - Maria Noureen
AU  - Sadaf Fatima
AU  - Ali Saqlain
AU  - Laksh Kumar
AU  - Adarsh Raja
PY  - 2026
JO  - Journal of Diabetes &amp; Metabolic Disorders
DO  - 10.1007/s40200-026-02108-x
UR  - https://doi.org/10.1007/s40200-026-02108-x
ER  -

APA

Wajid, R., Kumar, R., Muneer, M., Ali, M. N., Mustafa, J. U., Qamar, J., Asif, D., Ziaulhaque, S., Sohail, I., Khamisani, F. A., Noureen, M., Fatima, S., Saqlain, A., Kumar, L., & Raja, A. (2026). Efficacy and safety of semaglutide versus placebo in adults with overweight or obesity without diabetes: updated meta-analysis of randomized trials. Journal of Diabetes & Metabolic Disorders. https://doi.org/10.1007/s40200-026-02108-x

Source records

crossref · retrieved 2026-11-04T04:15:55.584Z